These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3923876)

  • 21. Platelet reactivity in vitro in relation to thromboxane in healthy pregnancy.
    Horn EH; Hardy E; Cooper J; Heptinstall S; Rubin PC
    Thromb Haemost; 1996 Feb; 75(2):346-51. PubMed ID: 8815588
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Licofelone, an inhibitor of cyclooxygenase and 5-lipoxygenase, specifically inhibits cyclooxygenase-1-dependent platelet activation.
    Rotondo S; Krauze-Brzósko K; Manarini S; Evangelista V; Cerletti C
    Eur J Pharmacol; 2004 Mar; 488(1-3):79-83. PubMed ID: 15044038
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Platelet aggregation: inhibition of secondary aggregation by phenol.
    Coan ML; Case KR; Bosmann HB
    Res Commun Chem Pathol Pharmacol; 1982 May; 36(2):241-9. PubMed ID: 6808618
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Variable platelet response to aspirin in patients with ischemic stroke.
    Hohlfeld T; Weber AA; Junghans U; Schumacher M; Boucher M; Schrör K; Siebler M
    Cerebrovasc Dis; 2007; 24(1):43-50. PubMed ID: 17519543
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased platelet prostaglandin and thromboxane synthesis in diabetes mellitus.
    Halushka PV; Rogers RC; Loadholt CB; Wohltman H; Mayfield R; McCoy S; Colwell JA
    Horm Metab Res Suppl; 1981; 11():7-11. PubMed ID: 7033097
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biochemical and pharmacological effects of dipyrone and its metabolites in model systems related to arachidonic acid cascade.
    Weithmann KU; Alpermann HG
    Arzneimittelforschung; 1985; 35(6):947-52. PubMed ID: 3927930
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 2-(2-Br-phenyl)-8-methoxy-benzoxazinone (HPW-RX2), a direct thrombin inhibitor with a suppressive effect on thromboxane formation in platelets.
    Wu CC; Wang TW; Wang WY; Hsieh PW; Wu YC
    Eur J Pharmacol; 2005 Dec; 527(1-3):37-43. PubMed ID: 16313903
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Platelet activation by superoxide anion and hydroxyl radicals intrinsically generated by platelets that had undergone anoxia and then reoxygenated.
    Leo R; Praticò D; Iuliano L; Pulcinelli FM; Ghiselli A; Pignatelli P; Colavita AR; FitzGerald GA; Violi F
    Circulation; 1997 Feb; 95(4):885-91. PubMed ID: 9054746
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of droxicam on in vivo prostaglandin synthesis and ex vivo platelet aggregation.
    Esteve J; Martínez L; Roser R; Sagarra R
    Methods Find Exp Clin Pharmacol; 1987 Apr; 9(4):209-13. PubMed ID: 3110512
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of dehydroepiandrosterone on platelet aggregation, superoxide dismutase activity and serum lipid peroxide concentrations in rabbits with induced hypercholesterolemia.
    Bednarek-Tupikowska G; Gosk I; Szuba A; Bohdanowicz-Pawlak A; Kosowska B; Bidzińska B; Milewicz A
    Med Sci Monit; 2000; 6(1):40-5. PubMed ID: 11208281
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of a single oral dose of aspirin on the platelet aggregation response to arachidonic acid.
    Bye A; Lewis Y; O'Grady J
    Br J Clin Pharmacol; 1979 Mar; 7(3):283-6. PubMed ID: 427005
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Morphological aspects of ferrous salts-induced lipid peroxidation and platelet aggregation in human blood.
    Villalobos MA; de la Cruz JP; Smith-Agreda JM; Sanchez de la Cuesta F
    Methods Find Exp Clin Pharmacol; 1990 Nov; 12(9):637-40. PubMed ID: 2128106
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of arachidonic acid on the aggregability of human platelet rich plasma.
    Dahl ML; Puustinen T; Uotila P
    Prostaglandins Leukot Med; 1982 Feb; 8(2):133-9. PubMed ID: 6804991
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of 12-lipoxygenase products of arachidonic acid on platelet aggregation.
    Morita I; Murota S
    Adv Prostaglandin Thromboxane Leukot Res; 1987; 17A():219-23. PubMed ID: 2821757
    [No Abstract]   [Full Text] [Related]  

  • 35. [Mechanism of the effect of aspirin on the functional properties of thrombocytes].
    Baluda VP; Shiriaev VV; Simova N; Georgievskaia B
    Biull Eksp Biol Med; 1977 Apr; 83(4):434-5. PubMed ID: 857970
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Definition of platelet-derived histamine releasing factor (PDHRF) and histaminergic receptors modulating platelet aggregation.
    Masini E; Pistelli A; Gambassi F; Di Bello MG; Mannaioni PF
    Adv Prostaglandin Thromboxane Leukot Res; 1991; 21B():533-6. PubMed ID: 1705080
    [No Abstract]   [Full Text] [Related]  

  • 37. The effect of superoxide dismutase and catalase on metabolism of 3H-arachidonic acid by washed platelets.
    Ellis EF; Cockrell CS
    Prostaglandins Leukot Med; 1984 Feb; 13(2):153-7. PubMed ID: 6425862
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Action mechanism of platelet suppressants and platelet suppressant therapy].
    Arimori S
    Nihon Rinsho; 1981; 39(12):3796-812. PubMed ID: 6803037
    [No Abstract]   [Full Text] [Related]  

  • 39. [Role of platelets in arterial hypotension induced by arachidonic acid and in carrageenan induced edema in the rat].
    Damas J; Volon G
    C R Seances Soc Biol Fil; 1979; 173(4):843-8. PubMed ID: 160830
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional and biochemical characterization of immunologically derived equine platelet-activating factor.
    Wimberly HC; Slauson DO; Neilsen NR
    Vet Pathol; 1985 Jul; 22(4):375-86. PubMed ID: 4035942
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.